The purpose of this document is to provide implementation guidance for programs directly funded by CDC interested in implementing new or expanding existing syringe services programs (SSPs) for persons who inject drugs (PWID).
The purpose of these guidelines is to provide healthcare providers in the United States with updated guidelines to the 2005 U.S. Department of Health and Human Services nonoccupational postexposure prophylaxis (nPEP) recommendations on the use of antiretroviral nPEP and other aspects of case management for persons with isolated exposure outside healthcare settings.
On April 18, CDC will join our partners to observe the inaugural National Transgender HIV Testing Day, sponsored by the Center of Excellence for Transgender Health, at the University of California, San Francisco.
The U.S. is experiencing a growing opioid epidemic, which has made many communities vulnerable to outbreaks of HIV and viral hepatitis among people who inject drugs (PWID). To address this issue, Members of Congress worked together late last year on a broad, bipartisan basis to revise a longstanding ban on the use of federal funds for Syringe Services Programs (SSPs).